glp-1 agonis receptor agonists show promise in treating substance use disorders GLP-1 receptor agonists for individualized

Keep out of reach of children under 18

In a randomized phase 3a study published in Diabetes Care, those taking oral semaglutide monotherapy experienced superior and clinically significant improvements in A1c and weight loss compared to those taking Continue reading Oral GLP-1 RA lowers Weight and A1c

From weight loss breakthroughsto type 2 diabetes management, and even anti-aging medicine, these treatments offer extraordinary promise.But with innovation comes risk

Wondering if you can take your semaglutide shot a day early

Discover how naturopathy supports natural GLP-1 production and improves insulin resistance through gut health, nutrition, stress management, and lifestyle changes.